Millennium Management LLC and Affiliates File Schedule 13G for AnaptysBio, Inc.

Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander have filed a Schedule 13G with the SEC, disclosing their beneficial ownership of 5.1% of the common stock of AnaptysBio, Inc. The filing, made under Rule 13d-1(c), indicates that the shares are held by entities subject to voting control and investment discretion by Millennium Management LLC and/or other investment managers controlled by Millennium Group Management LLC and Mr. Englander. The filing includes a Joint Filing Agreement, confirming that the Schedule 13G is filed on behalf of all three entities. The filing does not indicate any intent to influence the control of AnaptysBio, Inc.